Impact of COVID-19 on cardiovascular disease

I Vosko, A Zirlik, H Bugger - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

The role of pro-Inflammatory cytokines in the pathogenesis of cardiovascular disease

H Zhang, NS Dhalla - International Journal of Molecular Sciences, 2024 - mdpi.com
With cardiovascular disease (CVD) being a primary source of global morbidity and mortality,
it is crucial that we understand the molecular pathophysiological mechanisms at play …

Inflammatory and molecular pathways in heart failure—ischemia, HFpEF and transthyretin cardiac amyloidosis

D Michels da Silva, H Langer, T Graf - International journal of molecular …, 2019 - mdpi.com
Elevated pro-inflammatory biomarkers and cytokines are associated with morbidity and
mortality in heart failure (HF). Preclinical and clinical studies have shown multiple …

Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes

T Salvatore, R Galiero, A Caturano, E Vetrano… - Biomolecules, 2022 - mdpi.com
Cardiovascular (CV) disease and heart failure (HF) are the leading cause of mortality in type
2 diabetes (T2DM), a metabolic disease which represents a fast-growing health challenge …

Do interleukin-1 and interleukin-6 antagonists hold any place in the treatment of atherosclerotic cardiovascular disease and related co-morbidities? an overview of …

A Dimosiari, D Patoulias, GD Kitas… - Journal of Clinical …, 2023 - mdpi.com
Cardiovascular disease (CVD) constitutes a real pandemic of the 21st century. According to
data from the Centers for Disease Control and Prevention, one person dies every 34 min …

Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models

V Quagliariello, M Passariello, D Rea… - Journal of Personalized …, 2020 - mdpi.com
Background: Several strategies based on immune checkpoint inhibitors (ICIs) have been
developed for cancer therapy, opening to advantages in cancer outcomes. However, several …

NLRP3 inflammasome inhibitors in cardiovascular diseases

E Mezzaroma, A Abbate, S Toldo - Molecules, 2021 - mdpi.com
Virtually all types of cardiovascular diseases are associated with pathological activation of
the innate immune system. The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD) …

Heart failure in menopause: treatment and new approaches

JS da Silva, TL Montagnoli, MPL de Sá… - International Journal of …, 2022 - mdpi.com
Aging is an important risk factor for the development of heart failure (HF) and half of patients
with HF have preserved ejection fraction (HFpEF) which is more common in elderly women …

Obesity, preserved ejection fraction heart failure, and left ventricular remodeling

J Stencel, HR Alai, A Dhore-Patil… - Journal of Clinical …, 2023 - mdpi.com
Owing to the overwhelming obesity epidemic, preserved ejection fraction heart failure
commonly ensues in patients with severe obesity and the obese phenotype of preserved …

The different pathways of epicardial adipose tissue across the heart failure phenotypes: from pathophysiology to therapeutic target

VA Rossi, M Gruebler, L Monzo, A Galluzzo… - International Journal of …, 2023 - mdpi.com
Epicardial adipose tissue (EAT) is an endocrine and paracrine organ constituted by a layer
of adipose tissue directly located between the myocardium and visceral pericardium. Under …